These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21971618)

  • 41. Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.
    Couture F; Turner AR; Melosky B; Xiu L; Plante RK; Lau CY; Quirt I
    Oncologist; 2005 Jan; 10(1):63-71. PubMed ID: 15632253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Erythropoietin: current status.
    Bunn HF
    Yale J Biol Med; 1990; 63(5):381-6. PubMed ID: 2293499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Developments in the therapeutic use of erythropoiesis stimulating agents.
    Jelkmann W
    Br J Haematol; 2008 May; 141(3):287-97. PubMed ID: 18410567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of erythropoietin in the treatment of cancer-related anemia].
    Huang JX; Meng FJ
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):877-8. PubMed ID: 22335959
    [No Abstract]   [Full Text] [Related]  

  • 46. Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis.
    Mirtsching B; Charu V; Vadhan-Raj S; Colowick AB; Rossi G; Tomita D; McGuire WP
    Oncology (Williston Park); 2002 Oct; 16(10 Suppl 11):31-6. PubMed ID: 12435171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study Group.
    Biggs JC; Atkinson KA; Booker V; Concannon A; Dart GW; Dodds A; Downs K; Szer J; Turner J; Worthington R
    Bone Marrow Transplant; 1995 Jan; 15(1):129-34. PubMed ID: 7742745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxygen breathing may be a cheaper and safer alternative to exogenous erythropoietin (EPO).
    Burk R
    Med Hypotheses; 2007; 69(6):1200-4. PubMed ID: 17493766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Darbepoetin alfa: potential role in managing anemia in cancer patients.
    Pirker R; Smith R
    Expert Rev Anticancer Ther; 2002 Aug; 2(4):377-84. PubMed ID: 12647980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erythropoietin in cancer: an update.
    Tóvári J; Pirker R; Tímár J; Ostoros G; Kovács G; Döme B
    Curr Mol Med; 2008 Sep; 8(6):481-91. PubMed ID: 18781955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of erythropoietin in cancer-related anaemia: a double-edged sword?
    Guan X; Chen L
    J Int Med Res; 2008; 36(1):1-8. PubMed ID: 18230261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant human erythropoietin in the treatment of anemic patients with hematological malignancies.
    Kasper C
    Ann Hematol; 2001 Jun; 80(6):319-29. PubMed ID: 11475144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erythropoietin in urologic oncology.
    Albers P; Heicappell R; Schwaibold H; Wolff J;
    Eur Urol; 2001 Jan; 39(1):1-8. PubMed ID: 11173931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum immunoreactive erythropoietin in health and disease.
    Spivak JL
    J Perinat Med; 1995; 23(1-2):13-7. PubMed ID: 7658313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correction of cancer anemia--impact on disease course, prognosis and treatment efficacy, particularly for patients undergoing radiotherapy.
    Henke M
    Onkologie; 2001 Oct; 24(5):450-4. PubMed ID: 11694771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Erythropoietin and transfusions among critically ill patients.
    Bagshaw SM; Ghali WA
    JAMA; 2003 Mar; 289(12):1511; author reply 1512. PubMed ID: 12672766
    [No Abstract]   [Full Text] [Related]  

  • 57. Application of recombinant human erythropoietin in oncology.
    Spivak JL
    Cancer Invest; 1990; 8(2):301-2. PubMed ID: 2400953
    [No Abstract]   [Full Text] [Related]  

  • 58. [Erythropoietin for patients with malignant disease. An analysis of a systematic Cochrane review].
    Specht LK; Rørth M
    Ugeskr Laeger; 2006 Feb; 168(6):566-9. PubMed ID: 16476216
    [No Abstract]   [Full Text] [Related]  

  • 59. Erythropoietin and cancer.
    Sadoff L
    JAMA; 2005 Apr; 293(15):1858; author reply 1858-9. PubMed ID: 15840858
    [No Abstract]   [Full Text] [Related]  

  • 60. The use of erythropoietin.
    Langston CE; Reine NJ; Kittrell D
    Vet Clin North Am Small Anim Pract; 2003 Nov; 33(6):1245-60. PubMed ID: 14664197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.